Paper41279164
Hypoxia Imaging as a Radiomics Signature in Tumors Using Novel 19F-Eu-Based Contrast Agents for Magnetic Resonance Imaging.
White SA and 6 others. bioRxiv, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Hypoxia Imaging as a Radiomics Signature in Tumors Using Novel 19F-Eu-Based Contrast Agents for Magnetic Resonance Imaging. Papers, record 41279164. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41279164
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypoxia Imaging as a Radiomics Signature in Tumors Using Novel 19F-Eu-Based Contrast Agents for Magnetic Resonance Imaging.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 EB026453 | NIBIB NIH HHS | United States | R01EB026453 | PubMed and NIH |
Source NIH RePORTER
References156
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20639813 | Multimodality imaging of hypoxia in preclinical settings. | Q J Nucl Med Mol Imaging | 2010 | https://conductscience.org/library/papers/20639813 | PubMed |
| 2 | 25226090 | Structure-redox-relaxivity relationships for redox responsive manganese-based magnetic resonance imaging probes. | Inorg Chem | 2014 | https://conductscience.org/library/papers/25226090 | PubMed |
| 3 | 24992373 | Redox-triggered self-assembly of gadolinium-based MRI probes for sensing reducing environment. | Bioconjug Chem | 2014 | https://conductscience.org/library/papers/24992373 | PubMed |
| 4 | 37018203 | Toward quantification of hypoxia using fluorinated EuII/III-containing ratiometric probes. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37018203 | PubMed |
| 5 | 23162162 | Interaction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance Imaging. | Inorganica Chim Acta | 2012 | https://conductscience.org/library/papers/23162162 | PubMed |
| 6 | 19519402 | Hypoxia and radiation therapy: past history, ongoing research, and future promise. | Curr Mol Med | 2009 | https://conductscience.org/library/papers/19519402 | PubMed |
| 7 | 28393130 | Oxidation-Responsive, EuII/III-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging. | ACS Omega | 2017 | https://conductscience.org/library/papers/28393130 | PubMed |
| 8 | 30392757 | Convection-Enhanced Delivery in the Treatment of Glioblastoma. | Semin Oncol Nurs | 2018 | https://conductscience.org/library/papers/30392757 | PubMed |
| 9 | 26212717 | Hypoxia Induces Production of L-2-Hydroxyglutarate. | Cell Metab | 2015 | https://conductscience.org/library/papers/26212717 | PubMed |
| 10 | 33080334 | Blood oxygenation level dependent magnetic resonance imaging and diffusion weighted MRI imaging for benign and malignant breast cancer discrimination. | Magn Reson Imaging | 2021 | https://conductscience.org/library/papers/33080334 | PubMed |
| 11 | 33059825 | Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions. | Semin Nucl Med | 2020 | https://conductscience.org/library/papers/33059825 | PubMed |
| 12 | 21670155 | Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. | Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21670155 | PubMed |
| 13 | 22740186 | Synthesis and characterization of a hypoxia-sensitive MRI probe. | Chemistry | 2012 | https://conductscience.org/library/papers/22740186 | PubMed |
| 14 | 32606004 | MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer. | Cancer Res | 2020 | https://conductscience.org/library/papers/32606004 | PubMed |
| 15 | 34060485 | Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34060485 | PubMed |
| 16 | 25722934 | Convection-enhanced drug delivery for gliomas. | Surg Neurol Int | 2015 | https://conductscience.org/library/papers/25722934 | PubMed |
| 17 | 24508030 | Hypoxia and hypoxia inducible factors in tumor metabolism. | Cancer Lett | 2015 | https://conductscience.org/library/papers/24508030 | PubMed |
| 18 | 23916888 | Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment. | Nanomedicine | 2014 | https://conductscience.org/library/papers/23916888 | PubMed |
| 19 | 27533040 | Tumour hypoxia causes DNA hypermethylation by reducing TET activity. | Nature | 2016 | https://conductscience.org/library/papers/27533040 | PubMed |
| 20 | 29859790 | DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma. | Int J Radiat Oncol Biol Phys | 2018 | https://conductscience.org/library/papers/29859790 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41279164
GET https://conductscience.org/api/papers/v1/41279164/references?page=2